| Impact of medication adherence on risk of ischemic stroke, major bleeding and deep vein thrombosis in atrial fibrillation patients using novel oral anticoagulants CG Deshpande, S Kogut, R Laforge, C Willey Current medical research and opinion 34 (7), 1285-1292, 2018 | 50 | 2018 |
| Evaluating the utility of smartphone-based sensor assessments in persons with multiple sclerosis in the real-world using an app (elevateMS): observational, prospective pilot … A Pratap, D Grant, A Vegesna, M Tummalacherla, S Cohan, ... JMIR mHealth and uHealth 8 (10), e22108, 2020 | 49 | 2020 |
| Real-world health care costs based on medication adherence and risk of stroke and bleeding in patients treated with novel anticoagulant therapy CG Deshpande, S Kogut, C Willey Journal of managed care & specialty pharmacy 24 (5), 430-439, 2018 | 49 | 2018 |
| United States Patients’ perspective of living with migraine: country‐specific results from the global “my migraine voice” survey SN Gibbs, S Shah, CG Deshpande, ME Bensink, MS Broder, PK Dumas, ... Headache: The Journal of Head and Face Pain 60 (7), 1351-1364, 2020 | 27 | 2020 |
| Landscape of health-related quality of life in patients with early-stage pancreatic cancer receiving adjuvant or neoadjuvant chemotherapy: a systematic literature review T Macarulla, AE Hendifar, CP Li, M Reni, H Riess, MA Tempero, ... Pancreas 49 (3), 393-407, 2020 | 21 | 2020 |
| Annual cost burden by level of relapse severity in patients with multiple sclerosis J Nicholas, H Zhou, C Deshpande Advances in Therapy 38, 758-771, 2021 | 18 | 2021 |
| Longitudinal adaptive immune responses following sequential SARS-CoV-2 vaccinations in MS patients on anti-CD20 therapies and sphingosine-1-phosphate receptor modulators JJ Sabatino Jr, K Mittl, W Rowles, CR Zamecnik, RP Loudermilk, ... Multiple Sclerosis and Related Disorders 70, 104484, 2023 | 13 | 2023 |
| Real-world cost of treatment for multiple sclerosis patients initiating and receiving infused disease-modifying therapies per recommended label in the United States J Nicholas, R Halpern, M Ziehn, J Peterson-Brandt, M Leszko, ... Journal of Medical Economics 23 (8), 885-893, 2020 | 13 | 2020 |
| Cardiovascular hazards of insufficient treatment of depression among patients with known cardiovascular disease: a propensity score adjusted analysis S Bangalore, R Shah, E Pappadopulos, CG Deshpande, A Shelbaya, ... European Heart Journal-Quality of Care and Clinical Outcomes 4 (4), 258-266, 2018 | 13 | 2018 |
| Measuring recovery in opioid use disorder: clinical utility and psychometric properties of the Treatment Effectiveness Assessment W Ling, VR Nadipelli, CT Solem, D Farabee, NA Ronquest, B Perrochet, ... Substance Abuse and Rehabilitation, 13-21, 2019 | 12 | 2019 |
| The development of the ICIQ‐UAB: a patient reported outcome measure for underactive bladder AD Uren, N Cotterill, C Harding, C Hillary, C Chapple, K Lasch, A Stroupe, ... Neurourology and Urodynamics 38 (3), 996-1004, 2019 | 11 | 2019 |
| Serum neurofilament levels and patient‐reported outcomes in multiple sclerosis K Galetta, C Deshpande, BC Healy, B Glanz, M Ziehn, S Saxena, A Paul, ... Annals of Clinical and Translational Neurology 8 (3), 631-638, 2021 | 10 | 2021 |
| Economic burden associated with inadequate antidepressant medication management among patients with depression and known cardiovascular diseases: insights from a United States … S Bangalore, R Shah, X Gao, E Pappadopulos, CG Deshpande, ... Journal of medical economics 23 (3), 262-270, 2020 | 9 | 2020 |
| Analysis of treatment patterns and persistence on branded and generic medications in major depressive disorder using retrospective claims data EP Caitlyn T Solem,1 Ahmed Shelbaya,2,3 Yin Wan,1 Chinmay G Deshpande,1 Jose ... Neuropsychiatric Disease and Treatment 12, Pages 2755—2764, 2016 | 8 | 2016 |
| Evaluating the utility of smartphone-based sensor assessments in persons with multiple sclerosis in the real-world using an app (elevateMS): observational, prospective pilot … A Pratap, D Grant, A Vegesna, M Tummalacherla, S Cohan, ... | 7 | |
| Utilization and treatment patterns of disease-modifying therapy in pediatric patients with multiple sclerosis in the United States B Greenberg, S Kolodny, M Wang, C Deshpande International journal of MS care 23 (3), 101-105, 2021 | 5 | 2021 |
| Health-related quality of life (HRQoL), treatment satisfaction, and work productivity for patients (Pts) with advanced renal cell carcinoma (aRCC) in a chart review across six … R Hawkins, J Doan, C Deshpande, C Solem, S Yang, S Jiang, ... Journal of Clinical Oncology 35 (6_suppl), 487-487, 2017 | 4 | 2017 |
| Real-world use of ofatumumab to treat multiple sclerosis 9 months post-FDA approval during COVID-19 pandemic PK Coyle, M Gorritz, RL Wade, Z Zhou, S Khalid, EM Maiese, ... Multiple Sclerosis and Related Disorders 78, 104881, 2023 | 1 | 2023 |
| Longitudinal analysis of adaptive immunity following additional SARS-CoV-2 vaccination in MS patients on anti-CD20 therapies and sphingosine-1-phosphate receptor modulators JJ Sabatino Jr, K Mittl, WM Rowles, CR Zamecnik, RP Loudermilk, ... Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS …, 2022 | 1 | 2022 |
| Validation of the nontuberculous mycobacteria (NTM) module in NTM lung disease C Deshpande, A Quittner, E Chou, R Shah, S Bose, K Lasch, Q Zhang European Respiratory Journal 52 (suppl 62), 2018 | 1 | 2018 |
